Cargando…
The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL
Despite advances in the management of acute lymphoblastic leukaemia (ALL), current regimens fail to significantly transform outcomes for patients with high-risk subtypes. Advances in genomic analyses have identified novel lesions including mutations in genes that encode chromatin modifiers and those...
Autores principales: | Tavakoli Shirazi, Paniz, Eadie, Laura N., Heatley, Susan L., Hughes, Timothy P., Yeung, David T., White, Deborah L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028932/ https://www.ncbi.nlm.nih.gov/pubmed/31792348 http://dx.doi.org/10.1038/s41416-019-0647-7 |
Ejemplares similares
-
Mutational landscape of adult ETP-ALL
por: Neumann, Martin, et al.
Publicado: (2013) -
Comparison of characteristics and outcomes on ETP-ALL/LBL and non-ETP ALL patients receiving allogeneic hematopoietic stem cell transplantation
por: Chen, Juan, et al.
Publicado: (2023) -
RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL)
por: Rehn, Jacqueline, et al.
Publicado: (2022) -
Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL
por: Fransecky, L., et al.
Publicado: (2016) -
Studies on the Mechanisms of Chemical Leukaemogenesis
por: Dexter, T. M., et al.
Publicado: (1974)